Age-Dependent Cerebrovascular Abnormalities and Blood Flow Disturbances in APP23 Mice Modeling Alzheimer's Disease
暂无分享,去创建一个
Thomas Krucker | Thomas Mueggler | E. Meyer | M. Staufenbiel | N. Beckmann | T. Mueggler | K. Wiederhold | Karl-Heinz Wiederhold | T. Krucker | Nicolau Beckmann | A. Schuler | Matthias Staufenbiel | Alexandra Schuler | Eric P Meyer
[1] N. Patel,et al. Proinflammatory and Vasoactive Effects of Aβ in the Cerebrovasculature , 2002, Annals of the New York Academy of Sciences.
[2] D. Selkoe. Alzheimer's Disease Is a Synaptic Failure , 2002, Science.
[3] M. Kirkitadze,et al. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assemblies , 2002, Journal of neuroscience research.
[4] Markus Rudin,et al. Compromised Hemodynamic Response in Amyloid Precursor Protein Transgenic Mice , 2002, The Journal of Neuroscience.
[5] C. Iadecola,et al. Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. , 2002, American journal of physiology. Heart and circulatory physiology.
[6] W. K. Cullen,et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.
[7] Anders Wallin,et al. Increased intrathecal levels of the angiogenic factors VEGF and TGF-β in Alzheimer’s disease and vascular dementia , 2002, Neurobiology of Aging.
[8] D. Cornfield,et al. Aβ-peptides enhance vasoconstriction in cerebral circulation , 2001 .
[9] B. Lamb,et al. Transgenic mouse models of Alzheimer's disease. , 2001, Trends in genetics : TIG.
[10] J. Andersen,et al. Genetically engineered mice and their use in aging research , 2001, Molecular biotechnology.
[11] K. Duff,et al. Progress in the modeling of neurodegenerative diseases in transgenic mice , 2001, Current opinion in neurology.
[12] D. Westaway,et al. Transgenic mouse models of Alzheimer's disease , 2001, Physiology & Behavior.
[13] C. Finch,et al. Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum? , 2001, Trends in Neurosciences.
[14] M. Staufenbiel,et al. Spontaneous Hemorrhagic Stroke in a Mouse Model of Cerebral Amyloid Angiopathy , 2001, The Journal of Neuroscience.
[15] M. Staufenbiel,et al. Pathogenic Mechanisms of Alzheimer's Disease Analyzed in the APP23 Transgenic Mouse Model , 2000, Annals of the New York Academy of Sciences.
[16] N. Beckmann,et al. High resolution magnetic resonance angiography non‐invasively reveals mouse strain differences in the cerebrovascular anatomy in vivo , 2000, Magnetic resonance in medicine.
[17] Kang Hu,et al. High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.
[18] M. Jucker,et al. Mechanisms of Cerebrovascular Amyloid Deposition: Lessons from Mouse Models , 2000, Annals of the New York Academy of Sciences.
[19] P. Grammas. A damaged microcirculation contributes to neuronal cell death in Alzheimer’s disease☆ , 2000, Neurobiology of Aging.
[20] C. Broeckhoven,et al. Behavioral Disturbances without Amyloid Deposits in Mice Overexpressing Human Amyloid Precursor Protein with Flemish (A692G) or Dutch (E693Q) Mutation , 2000, Neurobiology of Disease.
[21] J. Detre,et al. Assessment of cerebral blood flow in Alzheimer's disease by spin‐labeled magnetic resonance imaging , 2000, Annals of neurology.
[22] B. Sommer,et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[23] N. Beckmann,et al. High-resolution magnetic resonance angiography of the mouse brain: application to murine focal cerebral ischemia models. , 1999, Journal of magnetic resonance.
[24] G. Arendash,et al. Intravascular β-amyloid infusion increases blood pressure: implications for a vasoactive role of β-amyloid in the pathogenesis of Alzheimer's disease , 1999, Neuroscience Letters.
[25] T. Reese,et al. Magnetic resonance angiography of the rat cerebrovascular system without the use of contrast agents , 1999, NMR in biomedicine.
[26] R. Nicoll,et al. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[27] Veerle Baekelandt,et al. Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain* , 1999, The Journal of Biological Chemistry.
[28] Mark A. Smith,et al. Cerebrovascular muscle atrophy is a feature of Alzheimer's disease , 1998, Brain Research.
[29] M. Uchiyama,et al. Latent cerebral artery stenoses on magnetic resonance angiography in a patient diagnosed as probable Alzheimer disease , 1998, Psychiatry and clinical neurosciences.
[30] B. Sommer,et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[31] T. Thomas,et al. beta-Amyloid induces cerebrovascular endothelial dysfunction in the rat brain. , 1997, Neurological research.
[32] D. Sparks. Coronary Artery Disease, Hypertension, ApoE, and Cholesterol: A Link to Alzheimer's Disease? , 1997, Annals of the New York Academy of Sciences.
[33] W. Markesbery,et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.
[34] M. Mullan,et al. β-Amyloid-mediated vasoactivity and vascular endothelial damage , 1996, Nature.
[35] J. D. L. Torre,et al. Can disturbed brain microcirculation cause Alzheimer’s disease? , 1993 .
[36] J. Hardy,et al. Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.
[37] B. Rosen,et al. Susceptibility contrast imaging of cerebral blood volume: Human experience , 1991, Magnetic resonance in medicine.
[38] T. Miyakawa,et al. Observations of Microvessels in the Brain with Alzheimer's Disease by the Scanning Electron Microscopy , 1991, The Japanese journal of psychiatry and neurology.
[39] J. Ulrich,et al. Alzheimer's Disease: A Description of the Structural Lesions , 1991, Brain pathology.
[40] Eric P. Meyer,et al. Corrosion casts as a method for investigation of the insect tracheal system , 1989, Cell and Tissue Research.
[41] Arnold B. Scheibel,et al. The Biological Substrates of Alzheimer's Disease , 1986 .
[42] D. Cornfield,et al. A beta-peptides enhance vasoconstriction in cerebral circulation. , 2001, American journal of physiology. Heart and circulatory physiology.
[43] G. Arendash,et al. Intravascular beta-amyloid infusion increases blood pressure: implications for a vasoactive role of beta-amyloid in the pathogenesis of Alzheimer's disease. , 1999, Neuroscience letters.
[44] B. Sommer,et al. TRANSGENIC ANIMAL MODELS IN THE DEVELOPMENT OF THERAPEUTIC STRATEGIES FOR ALZHEIMER’S DISEASE , 1998 .
[45] C. Haass. Molecular biology of Alzheimer's disease : genes and mechanisms involved in amyloid generation , 1998 .
[46] M. Rudin,et al. Analysis of tracer transit in rat brain after carotid artery and femoral vein administrations using linear system theory. , 1997, Magnetic resonance imaging.
[47] M. Mullan,et al. beta-Amyloid-mediated vasoactivity and vascular endothelial damage. , 1996, Nature.
[48] F Fazio,et al. Correlations between cognitive impairment, middle cerebral artery flow velocity and cortical glucose metabolism in the early phase of Alzheimer's disease. , 1995, Dementia.
[49] J. C. de la Torre,et al. Can disturbed brain microcirculation cause Alzheimer's disease? , 1993, Neurological research.